Medicines Australia (MA), the peak drug industry lobby group, has unveiled details of how much its 42 member companies (and one non-member) spent in the last half of 2007 on each one of over 14,000 events that were designed to promote their drugs to doctors.
A proposal before the Massachusetts state Senate to ban drug company gifts to doctors is generating controversy. "To imply that doctors who have invested years and tens of thousands of dollars in their profession can be bought with a dinner or a package of Post-its is beneath contempt," wrote the husband of one doctor. But Dr. Daniel J.
Subliminal advertising may be "more effective than regular advertising, because people don't have time to raise their anti-ad defenses," according to a new study.
In his new book True Enough: Learning to Live in a Post-Fact Society, Farhad Manjoo covers video news releases (VNRs) by looking a
In the brave new world of seemingly everyone having a MySpace page, publicity over alleged prostitution gave rise to a new online star at MySpace.
David Roberts of Grist.org writes in the Nation, "So there you have it: just in the past week, elite opinion against coal has accelerated, two major coal projects have run into embarrassments, and an independent report has confirmed that things are only going to get worse." Power consulting firm Wood MacKensie says that "the rate of coal plant cancellations accelerated during 2007 to the point that more than 50% of the new coal capacity announced since 2000 has now been canceled." On to
In early January, the U.S. House Committee on Energy and Commerce began investigating celebrity endorsements in television ads for brand-name drugs. The investigation was sparked by Pfizer's commercials for its best-selling cholesterol drug Lipitor. These direct-to-consumer (DTC) ads feature Dr. Robert Jarvik, a pioneer in the development of the artificial heart. Viewers are not told that Jarvik is not a cardiologist, nor is he licensed to practice medicine. His presentation as a trusted expert, Pfizer presumably hopes, is enough to persuade viewers to ask their doctors for Lipitor by name. And that would help erode the increasing competition from generic alternatives.